Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1- (β-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter

Xueqin Song, Balvinder S. Vig, Philip L. Lorenzi, John C. Drach, Leroy B. Townsend, Gordon L. Amidon

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Abstract

Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(βD-ribofuranosyl) benzimidazole (BDCRB) were synthesized and evaluated for their affinity for hPEPT1, an intestinal oligopeptide transporter. Assays of competitive inhibition of [3H]glycylsarcosine (Gly-Sar) uptake in HeLa/ hPEPT1 cells by the amino acid ester prodrugs of BDCRB suggested their 2- to 4-fold higher affinity for hPEPT1 compared to BDCRB. Further, promoieties with hydrophobic side chains and L-configuration were preferred by the hPEPT1 transporter.

Original languageEnglish (US)
Pages (from-to)1274-1277
Number of pages4
JournalJournal of Medicinal Chemistry
Volume48
Issue number4
DOIs
StatePublished - Feb 24 2005
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1- (β-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter'. Together they form a unique fingerprint.

Cite this